NCT06903611View on ClinicalTrials.gov

Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2027

Conditions
Dry Eye DiseaseDry EyeDry Eyes ChronicDry Eye Syndromes
Interventions
DRUG

CAM-101

fibrinogen depleted human platelet lysate

OTHER

Vehicle Control

Plasmalyte-A

Sponsors
All Listed Sponsors
lead

Cambium Bio Limited

INDUSTRY